A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells

Cancer Cell

Volumn 4, Issue 6, 2003, Pages 463-476

  Kau, Tweeny R ^a,b   Schroeder, Frank ^c   Ramaswamy, Shivapriya ^a,b   Wojciechowski, Cheryl L ^a,b   Zhao, Jean J ^a,b   Roberts, Thomas M ^a,b   Clardy, Jon ^a   Sellers, William R ^a,b   Silver, Pamela A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; BENZIMIDAZOLE DERIVATIVE; BENZOFURAN DERIVATIVE; BENZOXAZOLE DERIVATIVE; CALMIDAZOLIUM; CALMODULIN INHIBITOR; CARBAZOLE DERIVATIVE; CHLORPROMAZINE; CLOZAPINE; DIBENZOFURAN DERIVATIVE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; EXPORTIN 1; FLUPHENAZINE; HALOPERIDOL; INDOLE DERIVATIVE; N (4 AMINOBUTYL) 5 CHLORO 2 NAPSYLAMIDE; PHENANTHROLINE DERIVATIVE; PHENOTHIAZINE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROCHLORPERAZINE; PROTEIN KINASE B; QUINAZOLINE DERIVATIVE; STEPHOLIDINE; THIORIDAZINE; TRANSCRIPTION FACTOR FKHR; TRIFLUOPERAZINE; TYROSINE DERIVATIVE; UNINDEXED DRUG; WORTMANNIN;

ARTICLE; CARCINOGENICITY; CELL NUCLEUS; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DRUG STRUCTURE; ENZYME INHIBITION; GENETIC SCREENING; HUMAN; HUMAN CELL; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL;

EID: 0347747970     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00303-9     Document Type: Article

References (58)

1. Akakura S., Yoshida M., Yoneda Y., Horinouchi S. A role for Hsc70 in regulating nucleocytoplasmic transport of a temperature-sensitive p53 (p53Val-135). J. Biol. Chem. 276:2001;14649-14657.
2. Biggs W.H. 3rd, Meisenhelder J., Hunter T., Cavenee W.K., Arden K.C. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. USA. 96:1999;7421-7426.
3. Brami-Cherrier K., Valjent E., Garcia M., Pages C., Hipskind R.A., Caboche J. Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons. a new route to cAMP response element-binding protein phosphorylation J. Neurosci. 22:2002;8911-8921.
4. Brownawell A.M., Kops G.J., Macara I.G., Burgering B.M. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol. Cell. Biol. 21:2001;3534-3546.
5. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:1999;857-868.
6. Brunet A., Park J., Tran H., Hu L.S., Hemmings B.A., Greenberg M.E. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol. 21:2001;952-965.
7. Brunet A., Kanai F., Stehn J., Xu J., Sarbassova D., Frangioni J.V., Dalal S.N., DeCaprio J.A., Greenberg M.E., Yaffe M.B. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 156:2002;817-828.
8. Cheng A., Wang S., Yang D., Xiao R., Mattson M.P. Calmodulin mediates brain-derived neurotrophic factor cell survival signaling upstream of Akt kinase in embryonic neocortical neurons. J. Biol. Chem. 278:2003;7591-7599.
9. del Peso L., Gonzalez V.M., Hernandez R., Barr F.G., Nunez G. Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt. Oncogene. 18:1999;7328-7333.
10. Dong Z.J., Guo X., Chen L.J., Han Y.F., Jin G.Z. Dual actions of (-)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum. Life Sci. 61:1997;465-472.
11. Egea J., Espinet C., Soler R.M., Dolcet X., Yuste V.J., Encinas M., Iglesias M., Rocamora N., Comella J.X. Neuronal survival induced by neurotrophins requires calmodulin. J. Cell Biol. 154:2001;585-597.
12. Fornerod M., Ohno M., Yoshida M., Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell. 90:1997;1051-1060.
13. Fukuda M., Asano S., Nakamura T., Adachi M., Yoshida M., Yanagida M., Nishida E. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature. 390:1997;308-311.
14. Gerace L. Nuclear export signals and the fast track to the cytoplasm. Cell. 82:1995;341-344.
15. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA. 95:1998;2509-2514.
16. Henderson B.R., Eleftheriou A. A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. Exp. Cell Res. 256:2000;213-224.
17. Hietanen S., Lain S., Krausz E., Blattner C., Lane D.P. Activation of p53 in cervical carcinoma cells by small molecules. Proc. Natl. Acad. Sci. USA. 97:2000;8501-8506.
18. Imai S., Okayama N., Shimizu M., Itoh M. Increased intracellular calcium activates serum and glucocorticoid-inducible kinase 1 (SGK1) through a calmodulin-calcium calmodulin dependent kinase kinase pathway in Chinese hamster ovary cells. Life Sci. 72:2003;2199-2209.
19. Kau T.R., Silver P.A. Nuclear transport as a target for cell growth. Drug Discov. Today. 8:2003;78-85.
20. Kihara T., Shimohama S., Sawada H., Honda K., Nakamizo T., Kanki R., Yamashita H., Akaike A. Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade. J. Neurosci. Res. 70:2002;274-282.
21. Kondo K., Yao M., Kobayashi K., Ota S., Yoshida M., Kaneko S., Baba M., Sakai N., Kishida T., Kawakami S.et al. PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines. Int. J. Cancer. 91:2001;219-224.
22. Kong D., Suzuki A., Zou T.T., Sakurada A., Kemp L.W., Wakatsuki S., Yokoyama T., Yamakawa H., Furukawa T., Sato M.et al. PTEN1 is frequently mutated in primary endometrial carcinomas. Nat. Genet. 17:1997;143-144.
23. Kops G.J.P.L., de Ruier N.D., De Vries-Smits A.M.M., Powell D.R., Bos J.L., Burgering B.M.T. Direct control of the forkhead transcription factor AFX by protein kinase B. Nature. 398:1999;630-634.
24. Kudo N., Wolff B., Sekimoto T., Schreiner E.P., Yoneda Y., Yanagida M., Horinouchi S., Yoshida M. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242:1998;540-547.
25. Kudo N., Matsumori N., Taoka H., Fujiwara D., Schreiner E.P., Wolff B., Yoshida M., Horinouchi S. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl. Acad. Sci. USA. 96:1999;9112-9117.
26. Lain S., Midgley C., Sparks A., Lane E.B., Lane D.P. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp. Cell Res. 248:1999;457-472. a.
27. Lain S., Xirodimas D., Lane D.P. Accumulating active p53 in the nucleus by inhibition of nuclear export. a novel strategy to promote the p53 tumor suppressor function Exp. Cell Res. 253:1999;315-324. b.
28. Levin R.M., Weiss B. Mechanism by which psychotropic drugs inhibit adenosine cyclic 3′,5′-monophosphate phosphodiesterase of brain. Mol. Pharmacol. 12:1976;581-589.
29. Levin R.M., Weiss B. Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. Mol. Pharmacol. 13:1977;690-697.
30. Mack M.M., Molinski T.F., Buck E.D., Pessah I.N. Novel modulators of skeletal muscle FKBP12/calcium channel complex from Ianthella basta. Role of FKBP12 in channel gating. J. Biol. Chem. 269:1994;23236-23249.
31. Maehama T., Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273:1998;13375-13378.
32. Mazumdar A., Kumar R. Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells. FEBS Lett. 535:2003;6-10.
33. KIP1. Nature, 782-787.
34. Mottet D., Michel G., Renard P., Ninane N., Raes M., Michiels C. Role of ERK and calcium in the hypoxia-induced activation of HIF-1. J. Cell. Physiol. 194:2003;30-44.
35. Nakamura N., Ramaswamy S., Vazquez F., Signoretti S., Loda M., Sellers W.R. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol. 20:2000;8969-8982.
36. Neville M., Rosbash M. The NES-Crm1p export pathway is not a major mRNA export route in Saccharomyces cerevisiae. EMBO J. 18:1999;3746-3756.
37. Newlands E.S., Rustin G.J., Brampton M.H. Phase I trial of elactocin. Br. J. Cancer. 74:1996;648-649.
38. Ossareh-Nazari B., Bachelerie F., Dargemont C. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science. 278:1997;141-144.
39. Patel S., Freedman S., Chapman K.L., Emms F., Fletcher A.E., Knowles M., Marwood R., McAllister G., Myers J., Curtis N.et al. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. J. Pharmacol. Exp. Ther. 283:1997;636-647.
40. 1 progression by the PTEN tumor supressor protein is linked to inhibition of the phosphatidylinositol-3-kinase/ Akt pathway. Proc. Natl. Acad. Sci. USA. 96:1999;2110-2115.
41. Rena G., Guo S., Cichy S.C., Unterman T.G., Cohen P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J. Biol. Chem. 274:1999;17179-17183.
42. Rena G., Prescott A.R., Guo S., Cohen P., Unterman T.G. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targeting. Biochem. J. 354:2001;605-612.
43. Rena G., Woods Y.L., Prescott A.R., Peggie M., Unterman T.G., Williams M.R., Cohen P. Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J. 21:2002;2263-2271.
44. Stade K., Ford C.S., Guthrie C., Weis K. Exportin 1 (Crm1p) is an essential nuclear export factor. Cell. 90:1997;1041-1050.
45. Stein R.C., Waterfield M.D. PI3-kinase inhibition. a target for drug development? Mol. Med. Today. 6:2000;347-357.
46. Takaishi H., Konishi H., Matsuzaki H., Ono Y., Shirai Y., Saito N., Kitamura T., Ogawa W., Kasuga M., Kikkawa U., Nishizuka Y. Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc. Natl. Acad. Sci. USA. 96:1999;11836-11841.
47. Tang E.D., Nunez G., Barr F.G., Guan K.L. Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem. 274:1999;16741-16746.
48. Taura T., Krebber H., Silver P.A. A member of the Ran-binding protein family, Yrb2p, is involved in nuclear protein export. Proc. Natl. Acad. Sci. USA. 95:1998;7427-7432.
49. Vanhauwe J.F., Ercken M., van de Wiel D., Jurzak M., Leysen J.E. Effects of recent and reference antipsychotic agents at human dopamine D2 and D3 receptor signaling in Chinese hamster ovary cells. Psychopharmacology (Berl.). 150:2000;383-390.
50. Vazquez F., Sellers W.R. The PTEN tumor suppressor protein. an antagonist of phosphoinositide 3-kinase signaling Biochim. Biophys. Acta. 1470:2000;M21-M35.
51. Wang S.I., Puc J., Li J., Bruce J.N., Cairns P., Sidransky D., Parsons R. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res. 57:1997;4183-4186.
52. Wei J.W., Hickie R.A., Klaassen D.J. Inhibition of human breast cancer colony formation by anticalmodulin agents. trifluoperazine, W-7, and W-13 Cancer Chemother. Pharmacol. 11:1983;86-90.
53. Wolff B., Sanglier J.J., Wang Y. Leptomycin B is an inhibitor of nuclear export. inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA Chem. Biol. 4:1997;139-147.
54. Woods Y.L., Rena G., Morrice N., Barthel A., Becker W., Guo S., Unterman T.G., Cohen P. The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem. J. 355:2001;597-607.
55. Woscholski R., Kodaki T., McKinnon M., Waterfield M.D., Parker P.J. A comparison of demethoxyviridin and wortmannin as inhibitors of phosphatidylinositol 3-kinase. FEBS Lett. 342:1994;109-114.
56. Yang C., Watson R.T., Elmendorf J.S., Sacks D.B., Pessin J.E. Calmodulin antagonists inhibit insulin-stimulated GLUT4 (glucose transporter 4) translocation by preventing the formation of phosphatidylinositol 3,4,5-trisphosphate in 3T3L1 adipocytes. Mol. Endocrinol. 14:2000;317-326.
57. Yano S., Tokumitsu H., Soderling T.R. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature. 396:1998;584-587.
58. Zhao J.J., Gjoerup O.V., Subramanian R.R., Cheng Y., Chen W., Roberts T.M., Hahn W.C. Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell. 3:2003;483-495.